Texas Directs Healthcare Facilities to Align With FDA Medical Device Cybersecurity Guidance
State officials are urging hospitals to review device cybersecurity risks and align policies with FDA guidance.
State officials are urging hospitals to review device cybersecurity risks and align policies with FDA guidance.
New guidance permits the use of de-identified data without requiring individual patient information in marketing submissions.Â
New Sedgwick report shows Q2 2025 saw highest quarterly Class I medical device recalls in two decades, while agency launches generative AI tool for faster approvals.
State officials are urging hospitals to review device cybersecurity risks and align policies with FDA guidance.
A cybersecurity vulnerability that prompted Baxter to recall certain Life2000 ventilators is being seen by some industry experts as part of a broader shift in how the FDA treats software-related risks.Â
Read MoreThe voluntary recall involves pump modules that may have been repaired with FR-110 bezels, which the company says can weaken over time and compromise safe infusion delivery.
Read MoreUse with select infusion sets may lead to over- or under-infusion, bolus inaccuracies, and alarm delays, BD warns in recall notice.
Read MoreDesigned to reduce imaging artifacts during neurosurgery, the SonoClear System now has FDA Breakthrough Device status and is moving toward 510(k) submission.
Read MoreThe FDA has finalized guidance to assist medical device sponsors in addressing cybersecurity considerations as part of the premarket review process.
Read MoreNew white paper highlights the need to secure operational technologies used in medical product production.
Read More
Certain import devices from Olympus’ Aizu facility in Japan will be refused entry due to outstanding quality system violations, the FDA says.